Patient-centric trial aiming to evaluate whether bezisterim can help delay disease progression reaches enrollment milestone -- Topline Results ...

NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...

I recently sat down with Greg Alden, the CEO of Diagnostic Biochips (DBC), to discuss how he started with the company, how having Parkinson’s gives him a unique perspective on the company’s work, the ...

London - The doctors prepared to carry out the brain surgery, their medical tools laid out. Their patient, wide awake on the operating table, was given an instrument of her own: her clarinet, which ...

January 07, 2026-- NeuraLight, the leader in developing precision biomarkers for neurology, today announced the completion of PALOMA, a pioneering study comparing eye-movement measures with standard ...

There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain stimulator that could benefit patients with the motor condition. On Feb 24, ...

Explore off times in advanced Parkinson's disease, understand symptoms, communicate with your doctor, and consider treatment strategies and lifestyle adjustments.

Parkinson’s disease patients gathered for an afternoon of perseverance and laughter as Rock Steady Boxing celebrated seven ...

The Anidaso Parkinson’s Disease Foundation has thrown its support behind policy analyst Franklin Cudjoe following his public ...

Scientists have uncovered a connection between oral health and brain health. New research suggests that a common ...

Researchers at McGill University have uncovered a surprising twist in how dopamine affects movement, overturning a ...